Miami Herald

NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd

Anil R. Diwan, PhD, President and Executive Chairman of the Company will provide an update on the Company, its Drug Pipeline ...

FDA's top drug regulator quits as agency officials probe actions

The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his ...

FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’ about his conduct

The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing “serious concerns about his personal conduct,” according to a government ...
JD Supra

FDA readies for QMSR implementation with draft QMS information guidance: What manufacturers need to know

FDA recently issued the draft guidance, Quality Management System Information for Certain Premarket Submission Reviews. The guidance is designed ...

U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...

US FDA's drug division chief resigns amid ethics concerns and lawsuit

The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ...

FDA says clinical data for UniQure's Huntington's disease therapy not adequate

UniQure , said on Monday its experimental gene therapy for Huntington's disease does not have adequate clinical data to ...